Skip to main content
. Author manuscript; available in PMC: 2017 Feb 4.
Published in final edited form as: Nat Prod Rep. 2016 Feb 4;33(2):150–161. doi: 10.1039/c5np00112a

Figure 8.

Figure 8

(A) Structures of the engineered polyketide 2-propargylerythromycin, resulting from the selection of 2-propargylmalonate by AT5DEBS, and the pre-monensin series, derived from the feeding a variety of “non-native” precursors for generation of novel derivatives. (B) The two distinct routes established for the provision of fluoromalonyl-CoA (58) and the suite of fluorinated polyketide molecules generated from the minimal DEBS system.